CD274 and cancer: Surprisingly, combined treatment with these two drugs did not produce an additive effect on PD-L1 induction but rather resulted in PD-L1 expression levels that resembled the weaker PD-L1 inducer - ABE (Fig. 3A top and 3A bottom right), without reducing cancer cell cytotoxicity (Fig. S2).